Evidence map›Paper›PMID 22767148›Full record

ArticleBritish journal of cancer2012

A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy.

C J Talbot, G A Tanteles, G C Barnett, N G Burnet, J Chang-Claude, C E Coles, S Davidson, A M Dunning, J Mills, R J S Murray and 5 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2012
    Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Radiation biology and oncology in the genomic era.The British journal of radiology · 2018
    Review
  20. Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

C J TalbotDepartment of Genetics, University of Leicester, Adrian Building, University Road, Leicester LE1 7RH, UK. cjt14@le.ac.uk
G A Tanteles
G C Barnett
N G Burnet
J Chang-Claude
C E Coles
S Davidson
A M Dunning
J Mills
R J S Murray
O Popanda
P Seibold
C M L West
J R Yarnold
R P Symonds
Heidelberg University · DELeicester Royal Infirmary · GBCambridge University Hospitals NHS Foundation Trust · GBUniversity of Leicester · GBRoyal Marsden NHS Foundation Trust · GBThe Christie NHS Foundation Trust · GBUniversity of Cambridge · GBUniversity of Manchester · GB

Funding

Cancer Research UK
6 · The paper itself

Abstract

backgroundResponse to radiotherapy varies between individuals both in terms of efficacy and adverse reactions. Finding genetic determinants of radiation response would allow the tailoring of the treatment, either by altering the radiation dose or by surgery. Despite a growing number of studies in radiogenomics, there are no well-replicated genetic association results.

methodsWe carried out a candidate gene association study and replicated the result using three additional large cohorts, a total of 2036 women scored for adverse reactions to radiotherapy for breast cancer.

resultsGenetic variation near the tumour necrosis factor alpha gene is shown to affect several clinical endpoints including breast induration, telangiectasia and overall toxicity. In the combined analysis homozygosity for the rare allele increases overall toxicity (P=0.001) and chance of being in the upper quartile of risk with odds ratio of 2.46 (95% confidence interval 1.52-3.98).

conclusionWe have identified that alleles of the class III major histocompatibility complex region associate with overall radiotherapy toxicity in breast cancer patients by using internal replication through a staged design. This is the first well-replicated report of a genetic predictor for radiotherapy reactions.

Indexed as

Polymorphism, Single NucleotideBreast NeoplasmsCohort StudiesFemaleGenetic Association StudiesHumansRadiation InjuriesRadiotherapyRiskTumor Necrosis Factor-alphaTumor Necrosis Factor-alpha

Identifiers

PMID22767148
PMCPMC3419947
OpenAlexW2109317905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.